Efficacy and Safety of Upadacitinib in TNFi-IR Patients with Rheumatoid Arthritis from Three Phase 3 Clinical Trials

被引：0
|
作者：
Fleischmann, Roy [1 ,2 ]
Bessette, Louis [3 ]
Sparks, Jeffrey [4 ,5 ]
Hall, Stephen [6 ]
Jain, Manish [7 ]
Kakehasi, Adriana [8 ]
Song, Yanna [9 ]
Meerwein, Sebastian [10 ]
DeMasi, Ryan [9 ]
Suboticki, Jessica [11 ]
Rubbert-Roth, Andrea [12 ]
机构：
[1] Univ Texas South Western Med Ctr, Dallas, TX USA
[2] Metroplex Clin Res Ctr, Dallas, TX USA
[3] Ctr Ostoporose & Rhumatol Quebec, Quebec City, PQ, Canada
[4] Brigham & Womens Hosp, Boston, MA USA
[5] Harvard Med Sch, Boston, MA USA
[6] Emeritus Res & Monash Univ, Melbourne, Australia
[7] Great Lakes Clin Trials, Chicago, IL USA
[8] Univ Fed Minas Gerais, Hosp Clin, Belo Horizonte, MG, Brazil
[9] AbbVie Inc, N Chicago, IL USA
[10] AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany
[11] AbbVie Inc, Mettawa, IL USA
[12] Cantonal Clin St Gallen, Div Rheumatol, St Gallen, Switzerland
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0282
引用
收藏
页码：541 / 543
页数：3
相关论文
共 50 条
  • [21] Safety of tocilizumab in patients with rheumatoid arthritis: Pooled analysis of five phase 3 clinical trials
    Smolen, Josef S.
    Beaulieu, Andre D.
    Dikranian, Ara
    Fenton, Ira
    Fisheleva, Elena
    Alecock, Emma
    Emery, Paul
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S784 - S784
  • [22] Guselkumab Efficacy in Psoriatic Arthritis Assessed by Multi-domain Composite Indices: Data from the Phase 3b COSMOS Trial in a TNFi-IR Population
    Gossec, Laure
    Sharaf, Mohamed
    Theander, Elke
    Neuhold, Marlies
    Bergmans, Paul
    Shawi, May
    Perate, Michelle
    Contre, Christine
    Coates, Laura
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4172 - 4174
  • [23] Immunogenicity of sarilumab and impact on safety and efficacy in Japanese patients with rheumatoid arthritis: analysis of two Phase 3 randomised clinical trials
    Tanaka, Yoshiya
    Takahashi, Toshiya
    Sumi, Mariko
    Hagino, Owen
    Van Hoogstraten, Hubert
    Xu, Christine
    Kato, Naoto
    Kameda, Hideto
    MODERN RHEUMATOLOGY, 2022, 32 (04) : 686 - 695
  • [24] Leflunomide: Efficacy and safety in clinical trials for the treatment of rheumatoid arthritis
    Schiff, MH
    Strand, V
    Oed, C
    Loew-Friedrich, I
    DRUGS OF TODAY, 2000, 36 (06): : 383 - 394
  • [25] Safety Profile of Upadacitinib in Psoriatic Arthritis: Integrated Analysis from Two Phase 3 Trials
    Burmester, Gerd
    Winthrop, Kevin
    Nash, Peter
    Goupille, Philippe
    Azevedo, Valderilio F.
    Salvarani, Carlo
    McCaskill, Reva M.
    Liu, John
    Pierre-Louis, Bosny J.
    Anderson, Jaclyn K.
    Ruderman, Eric
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [26] SAFETY PROFILE OF UPADACITINIB IN PSORIATIC ARTHRITIS: INTEGRATED ANALYSIS FROM TWO PHASE 3 TRIALS
    Burmester, Gerd
    Winthrop, Kevin
    Nash, Peter
    Goupille, Philippe
    Azevedo, Valderilio F.
    Salvarani, Carlo
    McCaskill, Reva M.
    Liu, John
    Pierre-Louis, Bosny J.
    Anderson, Jaclyn K.
    Ruderman, Eric
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 46 - 46
  • [27] EFFECTS OF SMOKING ON BARICITINIB EFFICACY IN PATIENTS WITH RHEUMATOID ARTHRITIS: POOLED ANALYSIS FROM TWO PHASE 3 CLINICAL TRIALS
    Curtis, J.
    Emery, P.
    Burmester, G.
    Arora, V.
    Alam, J.
    Muram, D.
    Klareskog, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 244 - 244
  • [28] EXPOSURE-RESPONSE ANALYSES OF UPADACITINIB EFFICACY AND SAFETY IN RHEUMATOID ARTHRITIS - ANALYSES OF PHASE 2 AND 3 STUDIES
    Mohamed, Mohamed-Eslam
    Nader, Ahmed
    Winzenborg, Insa
    Doelger, Eva
    Noertersheuser, Peter
    Pangan, Aileen
    Othman, Ahmed
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 739 - 740
  • [29] The Association between Patient Reported Outcomes and Clinical Measures Among Rheumatoid Arthritis Patients: Analyses Using Phase 3 Clinical Trials of Upadacitinib
    Strand, Vibeke
    Damjanov, Nemanja
    Scoville, Craig
    Tundia, Namita
    Camp, Heidi S.
    Chen, Kun
    Suboticki, Jessica
    van Vollenhoven, Ronald
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [30] Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme
    Cohen, Stanley B.
    van Vollenhoven, Ronald F.
    Winthrop, Kevin L.
    Zerbini, Cristiano A. F.
    Tanaka, Yoshiya
    Bessette, Louis
    Zhang, Ying
    Khan, Nasser
    Hendrickson, Barbara
    Enejosa, Jeffrey, V
    Burmester, Gerd R.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (03) : 304 - 311
12345